How completely does Vical control the intellectual property/patents covering DNA vaccine technology?
Vical and its collaborators discovered the core technology underlying DNA vaccination in the late 1980s, and our patents have been the basis for multiple licensing agreements. 15. Anything else you think the public ought to know about DNA vaccines and Vical? Vical has recently been brought to the attention of many people because of our link to avian influenza. We would like these people to look beyond our avian flu effort to the broad range of other programs under independent and partnered development, all based on our patented technology. Our technology is broadly applicable for DNA vaccines, cancer immunotherapies, and angiogenesis programs. We would encourage interested parties to check our web site at www.vical.com for a more complete picture of the company.
